Victory Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $563K | Buy |
+27,650
| New | +$563K | ﹤0.01% | 2038 |
|
2025
Q1 | – | Sell |
-8,003
| Closed | -$202K | – | 2484 |
|
2024
Q4 | $202K | Sell |
8,003
-147
| -2% | -$3.72K | ﹤0.01% | 2233 |
|
2024
Q3 | $277K | Sell |
8,150
-172
| -2% | -$5.85K | ﹤0.01% | 2154 |
|
2024
Q2 | $308K | Buy |
8,322
+87
| +1% | +$3.22K | ﹤0.01% | 2093 |
|
2024
Q1 | $346K | Buy |
8,235
+983
| +14% | +$41.3K | ﹤0.01% | 2077 |
|
2023
Q4 | $288K | Buy |
+7,252
| New | +$288K | ﹤0.01% | 2139 |
|
2023
Q1 | – | Sell |
-5,096
| Closed | -$227K | – | 2609 |
|
2022
Q4 | $227K | Sell |
5,096
-6,673
| -57% | -$297K | ﹤0.01% | 2239 |
|
2022
Q3 | $331K | Sell |
11,769
-6,918
| -37% | -$195K | ﹤0.01% | 2210 |
|
2022
Q2 | $504K | Buy |
18,687
+1,263
| +7% | +$34.1K | ﹤0.01% | 2050 |
|
2022
Q1 | $532K | Buy |
17,424
+1,935
| +12% | +$59.1K | ﹤0.01% | 2103 |
|
2021
Q4 | $598K | Sell |
15,489
-4,188
| -21% | -$162K | ﹤0.01% | 2063 |
|
2021
Q3 | $1.06M | Sell |
19,677
-3,456
| -15% | -$187K | ﹤0.01% | 1839 |
|
2021
Q2 | $774K | Sell |
23,133
-3,632
| -14% | -$122K | ﹤0.01% | 1984 |
|
2021
Q1 | $551K | Buy |
26,765
+10,012
| +60% | +$206K | ﹤0.01% | 2160 |
|
2020
Q4 | $294K | Buy |
+16,753
| New | +$294K | ﹤0.01% | 2287 |
|
2020
Q2 | – | Sell |
-4,400
| Closed | -$8K | – | 2657 |
|
2020
Q1 | $8K | Buy |
+4,400
| New | +$8K | ﹤0.01% | 3354 |
|
2019
Q4 | – | Sell |
-1,796
| Closed | -$4K | – | 2755 |
|
2019
Q3 | $4K | Buy |
+1,796
| New | +$4K | ﹤0.01% | 3496 |
|
2017
Q2 | – | Sell |
-1,543
| Closed | -$6K | – | 1812 |
|
2017
Q1 | $6K | Hold |
1,543
| – | – | ﹤0.01% | 1797 |
|
2016
Q4 | $5K | Buy |
1,543
+86
| +6% | +$279 | ﹤0.01% | 1785 |
|
2016
Q3 | $6K | Buy |
1,457
+97
| +7% | +$399 | ﹤0.01% | 1770 |
|
2016
Q2 | $6K | Buy |
1,360
+26
| +2% | +$115 | ﹤0.01% | 1627 |
|
2016
Q1 | $5K | Buy |
1,334
+105
| +9% | +$394 | ﹤0.01% | 1653 |
|
2015
Q4 | $19K | Buy |
1,229
+66
| +6% | +$1.02K | ﹤0.01% | 1650 |
|
2015
Q3 | $12K | Buy |
1,163
+103
| +10% | +$1.06K | ﹤0.01% | 1601 |
|
2015
Q2 | $27K | Buy |
+1,060
| New | +$27K | ﹤0.01% | 1576 |
|